[1]
Sanjay Kalra, Saptarshi Bhattacharya and Nitin Kapoor 2022. Glucagon-Like Peptide 1 Receptor Agonists (GLP1RA) and Sodium-glucose co-transporter-2 inhibitors (SGLT2i): Making a pragmatic choice in diabetes management. Journal of the Pakistan Medical Association. 72, 5 (May 2022), 989–990. DOI:https://doi.org/10.47391/JPMA.22-64.